OrthoPediatrics priced its offering of 750,000 shares and, in lieu of common stock to Squadron Capital, pre-funded warrants to purchase up to 1,525,000 shares. The shares are being offered at $55 each and the pre-funded warrants are priced at $54.99975 per warrant. The pre-funded warrants have an exercise price of $0.00025 per share.
Gross proceeds of the offering to OrthoPediatrics, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $125 million. In addition, OrthoPediatrics has granted the underwriters a 30-day option to purchase up to an additional 341,250 shares.
The offering is expected to close Aug. 15. Read more.
